These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 28092161)
1. Estimation of ellagic acid and/or repaglinide effects on insulin signaling, oxidative stress, and inflammatory mediators of liver, pancreas, adipose tissue, and brain in insulin resistant/type 2 diabetic rats. Amin MM; Arbid MS Appl Physiol Nutr Metab; 2017 Feb; 42(2):181-192. PubMed ID: 28092161 [TBL] [Abstract][Full Text] [Related]
2. Ellagic Acid Alleviates Hepatic Oxidative Stress and Insulin Resistance in Diabetic Female Rats. Polce SA; Burke C; França LM; Kramer B; de Andrade Paes AM; Carrillo-Sepulveda MA Nutrients; 2018 Apr; 10(5):. PubMed ID: 29693586 [TBL] [Abstract][Full Text] [Related]
3. Hemin therapy suppresses inflammation and retroperitoneal adipocyte hypertrophy to improve glucose metabolism in obese rats co-morbid with insulin-resistant type-2 diabetes. Ndisang JF; Jadhav A Diabetes Obes Metab; 2013 Nov; 15(11):1029-39. PubMed ID: 23731386 [TBL] [Abstract][Full Text] [Related]
4. Hybrid drug combination: Anti-diabetic treatment of type 2 diabetic Wistar rats with combination of ellagic acid and pioglitazone. Nankar RP; Doble M Phytomedicine; 2017 Dec; 37():4-9. PubMed ID: 29103827 [TBL] [Abstract][Full Text] [Related]
5. Combined treatment of sinapic acid and ellagic acid attenuates hyperglycemia in streptozotocin-induced diabetic rats. Altındağ F; Rağbetli MÇ; Özdek U; Koyun N; Ismael Alhalboosi JK; Elasan S Food Chem Toxicol; 2021 Oct; 156():112443. PubMed ID: 34329744 [TBL] [Abstract][Full Text] [Related]
6. The effect of repaglinide on insulin secretion and oxidative stress in type 2 diabetic patients. Tankova T; Koev D; Dakovska L; Kirilov G Diabetes Res Clin Pract; 2003 Jan; 59(1):43-9. PubMed ID: 12482641 [TBL] [Abstract][Full Text] [Related]
7. Preventive effects of fenofibrate on insulin resistance, hyperglycaemia, visceral fat accumulation in NIH mice induced by small-dose streptozotocin and lard. Xie W; Nie Y; Du L; Zhang Y; Cai G Pharmacol Res; 2007 May; 55(5):392-9. PubMed ID: 17306985 [TBL] [Abstract][Full Text] [Related]
8. The combined effect of metformin and L-cysteine on inflammation, oxidative stress and insulin resistance in streptozotocin-induced type 2 diabetes in rats. Salman ZK; Refaat R; Selima E; El Sarha A; Ismail MA Eur J Pharmacol; 2013 Aug; 714(1-3):448-55. PubMed ID: 23845213 [TBL] [Abstract][Full Text] [Related]
9. Effects of repaglinide on oxidative stress in tissues of diabetic rabbits. Gumieniczek A Diabetes Res Clin Pract; 2005 May; 68(2):89-95. PubMed ID: 15860235 [TBL] [Abstract][Full Text] [Related]
10. Antioxidant and anti-inflammatory effects of Urtica pilulifera extracts in type 2 diabetic rats. Abo-elmatty DM; Essawy SS; Badr JM; Sterner O J Ethnopharmacol; 2013 Jan; 145(1):269-77. PubMed ID: 23159471 [TBL] [Abstract][Full Text] [Related]
12. Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats. Wang Y; Campbell T; Perry B; Beaurepaire C; Qin L Metabolism; 2011 Feb; 60(2):298-305. PubMed ID: 20304443 [TBL] [Abstract][Full Text] [Related]
13. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model. Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226 [TBL] [Abstract][Full Text] [Related]
14. [Mechanisms of action of repaglinide at a cellular level]. Thomsen MK Diabetes Metab; 1999 Dec; 25 Suppl 7():11-3. PubMed ID: 10746004 [TBL] [Abstract][Full Text] [Related]
15. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes. Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815 [TBL] [Abstract][Full Text] [Related]
16. Ankaflavin: a natural novel PPARγ agonist upregulates Nrf2 to attenuate methylglyoxal-induced diabetes in vivo. Lee BH; Hsu WH; Chang YY; Kuo HF; Hsu YW; Pan TM Free Radic Biol Med; 2012 Dec; 53(11):2008-16. PubMed ID: 23022408 [TBL] [Abstract][Full Text] [Related]
17. Oxidative stress and expression of insulin signaling proteins in the brain of diabetic rats: Role of Nigella sativa oil and antidiabetic drugs. Balbaa M; Abdulmalek SA; Khalil S PLoS One; 2017; 12(5):e0172429. PubMed ID: 28505155 [TBL] [Abstract][Full Text] [Related]
18. Ultrasonography modifications of visceral and subcutaneous adipose tissue after pioglitazone or glibenclamide therapy combined with rosuvastatin in type 2 diabetic patients not well controlled by metformin. Maffioli P; Fogari E; D'Angelo A; Perrone T; Derosa G Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1113-22. PubMed ID: 23524525 [TBL] [Abstract][Full Text] [Related]
19. Oxidative stress in kidney and liver of alloxan-induced diabetic rabbits: effect of repaglinide. Gumieniczek A Acta Diabetol; 2005 Jun; 42(2):75-81. PubMed ID: 15944840 [TBL] [Abstract][Full Text] [Related]
20. Clinical experience with repaglinide in patients with non-insulin-dependent diabetes mellitus. Shapiro MS; Abrams Z; Lieberman N Isr Med Assoc J; 2005 Feb; 7(2):75-7. PubMed ID: 15729954 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]